CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY
David Laharie 1
Corey A Siegel 2
Karen Samaan 3
Deborah Fisher 3
Nathan Morris 3
Isabel Redondo 3
Parambir Singh Dulai 4
Vipul Jairath 5
Javier Gisbert 6
Matsuoka Katsuyoshi 7
1 CHU de Bordeaux Hopital Haut-Leveque Dept. de Gastroenterologie, Pessac cedex, France
2 Dartmouth-Hitchcock Medical Center, Lebanon, United States
3 Eli Lilly and Company, Indianapolis, United States
4 Northwestern University, Chicago, United States
5 Western University, London, Canada
6 Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa and CIBEREHD, Madrid, Spain
7 Toho University Sakura Medical Center, Sakura, Japan
Topic
IBD
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]